Skip to content

Ferumoxsil

VARIOUS

Also known as: AMI-121, gastromark

FDA approvedATC V08CB01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ferumoxsil is a drug catalogued in DrugCentral. It was first approved by the FDA in 1996. Recorded indications include Magnetic resonance imaging.

  • Indications: Magnetic resonance imaging.
  • ATC code: V08CB01 (Superparamagnetic contrast media).

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Magnetic resonance imaging

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1996-12-06FDA—AMAG PHARMS INC

ATC classification

ATC codeTherapeutic hierarchy
V08CB01VARIOUS › CONTRAST MEDIA › MAGNETIC RESONANCE IMAGING CONTRAST MEDIA › Superparamagnetic contrast media

Chemical structure

Molecular formula—
Molecular weight—
CAS number171544-35-7
InChIKey—
PubChem CID—

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ferumoxsil used for?

DrugCentral lists the following indications for Ferumoxsil: Magnetic resonance imaging.

When was Ferumoxsil first approved?

Ferumoxsil was first approved by the FDA in 1996.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1996-12-06
AgencyFDA
Targets0
Indications1
Formula—
DrugCentral ID5146
Interactive profile